A study [51] unveiled that intratumoral administration of monoclonal antibodies against TSP-1 effectively curtailed tumor growth and metastasis, accompanied by an increase in tumor-specific tumor-infiltrating lymphocytes and systemic immune responses. The gene discussed is THBS1; the disease is neoplasm.